Azmi Nabulsi is Chief Operating Officer of Phathom Pharmaceuticals, Inc.. Currently has a direct ownership of 249,567 shares of PHAT, which is worth approximately $2.56 Million. The most recent transaction as insider was on May 31, 2024, when has been sold 7,500 shares (Common Stoock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 250K
3.1% 3M change
150.65% 12M change
Total Value Held $2.56 Million

Azmi Nabulsi Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2024
BUY
Grant, award, or other acquisition
-
7,500 Added 2.92%
249,567 Common Stoock
Nov 01 2023
BUY
Grant, award, or other acquisition
-
32,500 Added 11.84%
242,067 Common Stock
Jul 14 2023
BUY
Grant, award, or other acquisition
-
110,000 Added 34.42%
209,567 Common Stock
Apr 11 2023
BUY
Open market or private purchase
$82,600 $8.26 p/Share
10,000 Added 9.13%
99,567 Common Stock
Jan 19 2023
BUY
Grant, award, or other acquisition
-
45,000 Added 33.44%
89,567 Common Stock
Sep 01 2022
BUY
Grant, award, or other acquisition
-
7,500 Added 15.16%
41,971 Common Stock
May 19 2022
BUY
Grant, award, or other acquisition
-
12,000 Added 26.44%
33,378 Common Stock
Jan 19 2022
BUY
Grant, award, or other acquisition
-
19,500 Added 47.7%
21,378 Common Stock
Jun 25 2020
SELL
Bona fide gift
-
867,200 Reduced 100.0%
0 Common Stock
AN

Azmi Nabulsi

Chief Operating Officer
Florham Pak, NJ

Track Institutional and Insider Activities on PHAT

Follow Phathom Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAT shares.

Notify only if

Insider Trading

Get notified when an Phathom Pharmaceuticals, Inc. insider buys or sells PHAT shares.

Notify only if

News

Receive news related to Phathom Pharmaceuticals, Inc.

Track Activities on PHAT